https://www.selleckchem.com/pr....oducts/tideglusib.ht
tand clinicians' use of the pre-MET RRS tier to inform targeted strategies to optimise its design and implementation. We identified opportunities to improve guidance documents supporting the pre-MET RRS tier that may assist other health services engaged in planning or evaluating pre-MET strategies. Further research is needed to understand clinicians' use of the pre-MET RRS tier to inform targeted strategies to optimise its design and implementation. To determine the prevalence of leg ulcers, and to describe the affected patients, wou